Avadel Pharmaceuticals (AVDL) Interest Expenses (2016 - 2020)
Historic Interest Expenses for Avadel Pharmaceuticals (AVDL) over the last 7 years, with Q4 2020 value amounting to $3.3 million.
- Avadel Pharmaceuticals' Interest Expenses rose 369.91% to $3.3 million in Q4 2020 from the same period last year, while for Sep 2021 it was $3.3 million, marking a year-over-year decrease of 6584.76%. This contributed to the annual value of $10.8 million for FY2024, which is N/A changed from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Interest Expenses of $3.3 million as of Q4 2020, which was up 369.91% from $3.3 million recorded in Q3 2020.
- In the past 5 years, Avadel Pharmaceuticals' Interest Expenses registered a high of $3.3 million during Q4 2020, and its lowest value of $175000.0 during Q1 2016.
- In the last 5 years, Avadel Pharmaceuticals' Interest Expenses had a median value of $3.0 million in 2018 and averaged $1.8 million.
- In the last 5 years, Avadel Pharmaceuticals' Interest Expenses tumbled by 37.88% in 2017 and then surged by 105779.47% in 2018.
- Avadel Pharmaceuticals' Interest Expenses (Quarter) stood at $261000.0 in 2016, then grew by 0.77% to $263000.0 in 2017, then surged by 1057.79% to $3.0 million in 2018, then increased by 4.76% to $3.2 million in 2019, then rose by 3.7% to $3.3 million in 2020.
- Its Interest Expenses stands at $3.3 million for Q4 2020, versus $3.3 million for Q3 2020 and $3.2 million for Q2 2020.